Edition:
India

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

837.50INR
2:56pm IST
Change (% chg)

Rs11.35 (+1.37%)
Prev Close
Rs826.15
Open
Rs830.00
Day's High
Rs849.50
Day's Low
Rs829.00
Volume
2,091,735
Avg. Vol
2,192,049
52-wk High
Rs1,573.60
52-wk Low
Rs818.50

Latest Key Developments (Source: Significant Developments)

Lupin says U.S. FDA issues warning letter to co's Goa, Indore sites ‍​
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Lupin Ltd :Says U.S. FDA issues warning letter to co's Goa and Indore sites .Says likely delay of new product approvals from Goa, Pithampur facilities‍​‍​.There will be no disruption of exisiting product supplies from either of these locations ‍​.  Full Article

Lupin launches generic Acticlate tablets in U.S.‍​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Lupin Ltd ::Says co launches generic Acticlate tablets in U.S.‍​.  Full Article

Lupin says co on track with complex generic pipeline
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Lupin Ltd :Says on track with complex generic pipeline.Says as expected, co continues to see pricing pressure for its U.S. generic business .Says Lupin’s Q2 North America sales 13.61 billion rupees versus 19.98 billion rupees yoy.  Full Article

India's Lupin Sept-qtr consol profit down 31 pct
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Lupin Ltd ::Sept quarter consol net profit 4.55 billion rupees versus profit of 6.62 billion rupees last year.Sept quarter consol sales 38.74 billion rupees versus 42.11 billion rupees last year.Consensus forecast for Sept quarter consol profit was 4.33 billion rupees.  Full Article

Lupin gets USFDA nod for drug used in ADHD treatment
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Lupin Ltd :Says Lupin receives FDA approval for generic Kapvay extended-release tablets‍​.Drug indicated for the treatment of attention deficit hyperactivity disorder (ADHD) .  Full Article

Lupin gets U.S.FDA nod for generic Axirona topical solution‍​
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Lupin Ltd ::Says gets FDA nod for generic Axirona topical solution‍​.  Full Article

India's Lupin gets U.S. FDA nod for carbidopa tablets
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Lupin Ltd :Says gets U.S. FDA approval for carbidopa tablets, 25 mg.  Full Article

Lupin launches generic norcoâ tablets in the U.S.
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - Lupin Ltd :Says Lupin launches generic norcoâ tablets in the U.S..  Full Article

Lupin gets U.S. FDA nod for generic drug to treat chest pain, hypertension
Monday, 9 Oct 2017 

Oct 9 (Reuters) - Lupin Ltd ::Says gets FDA nod for generic Corgarda tablets .Says drug indicated for management of patients with angina pectoris and for the treatment of hypertension‍​‍​.  Full Article

Lupin receives U.S. FDA approval for generic Roxicodone tablets
Wednesday, 14 Jun 2017 

June 14 (Reuters) - Lupin Ltd ::Says Lupin receives FDA approval for generic Roxicodone tablets.receives FDA approval for its oxycodone hydrochloride tablets USP, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg.  Full Article

Photo

Yes Bank, IndusInd to join India's BSE Sensex index; Lupin, Cipla dropped

Indian private sector lenders Yes Bank Ltd and IndusInd Bank Ltd will join the BSE stock exchange's 30-member Sensex index, effective Dec. 18, the index provider said on Friday.